Stella+ - Integrating a HRT prescribing decision tool in primary care workflows

VIRA的目的是让全球10亿(1300万英国)更年期女性的生活更幸福、更健康、更有生产力。超过80%的人报告说症状干扰了日常生活，50%的人说这让工作变得困难或难以为继，每年有90万英国女性辞去工作。症状包括身体(潮热、体重增加、性欲减退)和心理(情绪波动、注意力难以集中、抑郁、焦虑)。更年期可能会对健康产生严重的长期影响：影响女性晚年生活的问题，包括心血管疾病、糖尿病、骨质疏松症和痴呆症，可能会在更年期引发。如果我们要及早解决这些问题，改善更年期治疗是当务之急。目前的护理模式已经被打破，10%的英国女性表示她们对所得到的护理感到满意。修复这一模式是跨党派议会更年期小组的一个关键优先事项，该小组提出了对女性的紧急帮助：增加工作场所的支持，为卫生工作者提供症状培训，改善获得治疗的机会，并对所有45岁的女性进行检查。为了解决这个问题，Vira设计了其Stella平台：我们的第一个产品_Stella_是一款针对女性的个性化更年期治疗和辅导应用程序，已经在改变症状管理。它使妇女能够单独或通过其工作场所订阅的B2B获得支持，包括锻炼和饮食计划、信息、在线瑜伽课、获得认知行为疗法等。该项目通过提供Stella+解决了培训卫生从业者和改善获得治疗的机会的具体问题。Stella+是一种针对更年期的临床评估工具，旨在支持全科医生和相关健康专业人员就激素替代疗法(HRT)的处方做出更好的决策，并优化治疗审查过程，更好地识别治疗无效、副作用和不良反应。Stella+将基于我们的IIa类算法来开出HRT。

Vira is motivated to make lives happier, healthier and more productive for the 1bn women worldwide (13m UK) coping with menopause. 80%+ report symptoms interfere with daily life and 50% say it has made work difficult or untenable, with 900k UK women quitting jobs annually. Symptoms include physical (hot flushes, weight gain, loss of libido) and psychological (mood swings, difficulty concentrating, depression, anxiety). Menopause can have severe long-term health implications: issues affecting women in later life, including cardiovascular disease, diabetes, osteoporosis and dementia, can be triggered at menopause. Improving treatment for menopause is urgently needed if we are to tackle these early on.The current care model is broken, with <10% of UK women saying they are happy with the care they receive. Fixing the model is a key priority of the All-Party Parliamentary Group on Menopause, which sets out need for urgent help for women: boosting support in the workplace, training on symptoms for health workers, improving access to treatment, and checks for all women at 45\.To address this, Vira has devised its Stella platform:Our first product, _Stella_, is a personalised menopause treatment and coaching app for women, and is already transforming symptom management. It enables women to access support --individually or via B2B subscriptions made by their workplace -- including exercise and diets plans, information, online yoga classes, access to cognitive behaviour therapy, etc.This project addresses the specific problems of training health practitioners and improving access to treatment by delivering Stella+. Stella+ is a clinical assessment tool for menopause, designed to support GPs and allied health professionals in making better decisions about prescriptions of hormone replacement therapy (HRT), and to optimise treatment review processes, with better identification of treatment ineffectiveness, side and adverse effects. Stella+ will build upon our Class IIa algorithms for prescribing HRT.